RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2603527241
